These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Survey of the published RBE values of the californium-252 emission: influence of dose rate. Van Dam J; Octave-Prignot M; Wambersie A J Belge Radiol; 1984; 67(3):183-91. PubMed ID: 6501209 [No Abstract] [Full Text] [Related]
4. The biological and medical importance of the isotope 252-californium: International Symposium on Californium. Vogel HH Biomedicine; 1977 Apr; 26(2):101-4. PubMed ID: 871517 [No Abstract] [Full Text] [Related]
5. [Relative biological effectiveness (RBE) of low-dose californium-252]. Van Dam J; Billiet G; Dutreix A; Wambersie A C R Seances Soc Biol Fil; 1982; 176(3):435-41. PubMed ID: 6215111 [TBL] [Abstract][Full Text] [Related]
6. RBE and OER determinations for radium and californium 252. Hall EJ; Roizin-Towle LA; Colvett RD Radiology; 1974 Mar; 110(3):699-704. PubMed ID: 4855804 [No Abstract] [Full Text] [Related]
7. [Relative biological effectiveness of 252Cf neutrons]. Riabukhin IuS Med Radiol (Mosk); 1985 Apr; 30(4):53-9. PubMed ID: 3887086 [No Abstract] [Full Text] [Related]
8. [Relative biological effectiveness of highly active mixed gamma-neutron 252Cf radiation]. Aleksandrov ID; Guliaev VA; Kolesnikova AI; Obaturov GM; Potetnia VI Med Radiol (Mosk); 1985 Jun; 30(6):37-40. PubMed ID: 3894854 [TBL] [Abstract][Full Text] [Related]
9. An assessment of RBE of Californium-252 for C57-Black/6 mouse fibrosarcoma by a precise afterloading technique. Moser FL; Lanzi LH; Mewissen DJ; Furedi EM; Rozenfeld M Radiology; 1975 Oct; 117(1):205-9. PubMed ID: 1162060 [TBL] [Abstract][Full Text] [Related]
10. Increased 252Cf therapeutic advantage for an advanced murine lymphoma (LSA) growing in vivo. Maruyama Y; Darwazeh NB; Magura C Br J Radiol; 1988 Apr; 61(724):312-6. PubMed ID: 3370416 [TBL] [Abstract][Full Text] [Related]
11. Survival of cultured human cells exposed to californium 252Cf radiation at low dose rates. Todd P; Feola JM; Maruyama Y Am J Clin Oncol; 1984 Oct; 7(5):495-8. PubMed ID: 6507369 [TBL] [Abstract][Full Text] [Related]
12. RBE values for californium -252; OER of hypoxic cells. Nias AH Br J Radiol; 1977 May; 50(593):373. PubMed ID: 861462 [No Abstract] [Full Text] [Related]
13. Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial. Maruyama Y; van Nagell JR; Yoneda J; Gallion HH; DePriest P; Feola JM; Wierzbicki J Am J Clin Oncol; 1993 Apr; 16(2):168-74. PubMed ID: 8452113 [TBL] [Abstract][Full Text] [Related]
14. Radiobiological background for use of 252 Cf sources--the data available at present. Berry RJ Br J Radiol; 1971 Nov; 44(527):902-3. PubMed ID: 5123609 [No Abstract] [Full Text] [Related]
15. Biophysical factors in brachytherapy with low- and high-LET radiations. Rossi HH; Hall EJ; Kellerer AM Radiology; 1973 Jun; 107(3):645-9. PubMed ID: 4735694 [No Abstract] [Full Text] [Related]
16. Compound dual radiation action theory for 252Cf brachytherapy. Wang CK; Zhang X Radiat Prot Dosimetry; 2004; 110(1-4):801-6. PubMed ID: 15353749 [TBL] [Abstract][Full Text] [Related]
17. Lethal and mutagenic effects of 252Cf radiation in cultured human cells. Ban S; Iida S; Awa AA; Sawada S Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):245-51. PubMed ID: 3497122 [TBL] [Abstract][Full Text] [Related]
18. [Biological action of the radiation from high-activity 252Cf sources]. Vaĭson AA; Meshcherikova VV; Chekhonadskiĭ VN; Spasokukotskaia ON Med Radiol (Mosk); 1987 Mar; 32(3):65-9. PubMed ID: 3561212 [TBL] [Abstract][Full Text] [Related]
19. [Survival of clonogenic cells of Lewis lung carcinoma cells forming colonies in agar cultures in diffusion chambers during gamma-irradiation and exposure to gamma-neutron californium-252 irradiation]. Konopliannikov AG; Lepekhina LA; Kolesnikova AI; Ermakov VI Radiobiologiia; 1986; 26(4):473-6. PubMed ID: 3749472 [TBL] [Abstract][Full Text] [Related]
20. [Principles of dosimetric planning in contact therapy with highly active Cf-252 sources]. Chekhonadskij VN; Merkle K Strahlenther Onkol; 1987 Nov; 163(11):742-5. PubMed ID: 3686338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]